Pages

Showing posts with label Pharmaceutical Market. Show all posts
Showing posts with label Pharmaceutical Market. Show all posts

Thursday, December 11, 2014

Zedira GmbH - Product Pipeline Review - 2014 - Market Trends, Share, Forecast

Description

Zedira GmbH - Product Pipeline Review - 2014

Summary

Global Markets Directs, Zedira GmbH - Product Pipeline Review - 2014, provides an overview of the Zedira GmbHs pharmaceutical research and development focus.

View Full Report At: http://www.marketresearchreports.biz/analysis/233454

This report provides comprehensive information on the current therapeutic developmental pipeline of Zedira GmbHs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Download Sample Of This Report: http://www.marketresearchreports.biz/sample/sample/233454

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Zedira GmbH including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Zedira GmbHs human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Zedira GmbHs pipeline products

Related Reports

Medivir AB - Product Pipeline Review - 2014

View Full Report At: http://www.marketresearchreports.biz/analysis/235173

The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Download Sample Of This Report: http://www.marketresearchreports.biz/sample/sample/235173

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Nuvo Research Inc. - Product Pipeline Review - 2014

View Full Report At: http://www.marketresearchreports.biz/analysis/235174

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings.

Download Sample Of This Report: http://www.marketresearchreports.biz/sample/sample/235174

The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones.
Special feature on out-licensed and partnered product portfolio.
The report summarizes all the dormant and discontinued pipeline projects.

Browse Our Press Releases by Prnewswire: http://www.prnewswire.com/news/marketresearchreports.biz 

About Us

Marketresearchreports.biz is the most comprehensive collection of market research reports. Marketresearchreports.biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

With a team of experienced consultants we are committed to serve our clients in a way which increase their efficiency, reduce costs and saves time. Our professional search engine helps you in finding the best and latest market research report with just one click of the mouse. Our database represents the most updates and latest market research report collections form all the leading market research publishers across the globe.

Key Points of Marketresearchreports.biz Process

Refining research query

Providing samples and summaries

Quick response time

Helping in making final purchase

Marketresearchreports.biz provides with latest market data and information covering various geographies, industries and companies. We offer special discounts and annual subscriptions to Governments, Embassies, Investment agencies, National statistics agencies, Trade unions, Leading
newspapers and Private publishers.

To get in touch with our Research Coordinators, call us on 866-997-4948 (Us-Canada Toll Free) or drop us an email at: sales@marketresearchreports.biz . We will get back in touch with you within 24 hours.

Kolon Life Science, Inc. - Product Pipeline Review - 2014 - Market Growth, Share

Description

Kolon Life Science, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Directs, Kolon Life Science, Inc. - Product Pipeline Review - 2014, provides an overview of the Kolon Life Science, Inc.s pharmaceutical research and development focus.

View Full Report At: http://www.marketresearchreports.biz/analysis/233451

This report provides comprehensive information on the current therapeutic developmental pipeline of Kolon Life Science, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Download Sample Of This Report: http://www.marketresearchreports.biz/sample/sample/233451

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Kolon Life Science, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Kolon Life Science, Inc.s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Kolon Life Science, Inc.s pipeline products

Related Reports

EpiCast Report: Acromegaly And Gigantism - Epidemiology Forecast To 2023

View Full Report At: http://www.marketresearchreports.biz/analysis/235086

Acromegaly and gigantism are rare disorders of the pituitary gland characterized by the hypersecretion of growth hormone (GH). GH excess beginning in adulthood is known as acromegaly, whereas GH excess beginning during childhood is known as gigantism.

Download Sample Of This Report: http://www.marketresearchreports.biz/sample/sample/235086

GlobalData epidemiologists forecast an increase in the diagnosed prevalent cases of acromegaly in the 6MM from 25,354 diagnosed prevalent cases in 2013 to 26,884 diagnosed prevalent cases in 2023, at an Annual Growth Rate (AGR) of 0.60% in the forecast period.

Asset Purchase Terms And Agreements In Pharma, Biotech And Diagnostics

View Full Report At: http://www.marketresearchreports.biz/analysis/93020

The Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the asset purchase agreements entered into by the worlds leading biopharma companies. The report provides a detailed understand and analysis of how and why companies enter asset purchase deals.

Download Sample Of This Report: http://www.marketresearchreports.biz/sample/sample/93020

This report contains a comprehensive listing of all asset purchase deals announced since 2009 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual asset purchase contract documents as submitted to the Securities Exchange Commission by companies and their partners.

Browse Our Press Releases by Prnewswire: http://www.prnewswire.com/news/marketresearchreports.biz 

About Us

Marketresearchreports.biz is the most comprehensive collection of market research reports. Marketresearchreports.biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

With a team of experienced consultants we are committed to serve our clients in a way which increase their efficiency, reduce costs and saves time. Our professional search engine helps you in finding the best and latest market research report with just one click of the mouse. Our database represents the most updates and latest market research report collections form all the leading market research publishers across the globe.

Key Points of Marketresearchreports.biz Process

Refining research query

Providing samples and summaries

Quick response time

Helping in making final purchase

Marketresearchreports.biz provides with latest market data and information covering various geographies, industries and companies. We offer special discounts and annual subscriptions to Governments, Embassies, Investment agencies, National statistics agencies, Trade unions, Leading
newspapers and Private publishers.

To get in touch with our Research Coordinators, call us on 866-997-4948 (Us-Canada Toll Free) or drop us an email at: sales@marketresearchreports.biz . We will get back in touch with you within 24 hours.

Thursday, March 20, 2014

The Pharmaceutical Market: Russia, Spain, United Kingdom, India, Finland : Market Research Reports


Market Research Reports          Market Research Reports.Biz announces addition of new report “ Pharmaceutical Market ” to its database.

The Russia, Spain, United Kingdom, India, Finland pharmaceutical market remains a powerhouse in the Emerging Europe region . The country has by far the largest population in the region. I ts resource s -driven economic growth is funding both private and public spending on medicines and healthcare services. The country's World Trade Organisation (WTO) accession has eliminated tariff barriers and should, in the long run, drive major improvements in a problematic intellectual property environment.

Visit Same Publisher Report: The Pharmaceutical Market: Russia, Spain, United Kingdom, India, Finland

Pharmaceutical MarketBoth domestic and cross-border mergers and acquisitions (M&A) activity has picked up since the 2009 economic crisis, a result of increased incentives for local production under the government's industrial policy for the sector and the need for scale to compete , especially in the generic medicines market. We believe a critical forward step for the market will be the successful implementation of a broad-based medicines insurance programmer in the next few years, following current pilot projects. If this proves successful, we would expect growth to outstrip our current five-year projection for a compound annual growth rate of 8.3% in US dollar terms during the period 2012-2017.

For More Latest Reports Under the Same Category: Pharmaceutical Market

Headline Expenditure Projections

Pharmaceuticals: RUB664.72bn (US$20.96bn) in 2012 to RUR728.00bn (US$22.40bn) in 2013; +9.5% in local currency terms and 6.9% in US dollar terms. Forecast is virtually unchanged from Q412.
Healthcare: RUB2,709.62 (US$85.42bn) in 2012 to RUB2928.54bn (US$90.11bn) in 2013; +8.1% in local currency terms and +5.5% in US dollar terms. Forecast is virtually unchanged from Q412.

Competitive Landscape

The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

Table of Content

Executive Summary
SWOT Analysis
Russia, Spain, United Kingdom, India, Finland Pharmaceuticals And Healthcare Industry SWOT
Russia, Spain, United Kingdom, India, Finland Political SWOT
Russia, Spain, United Kingdom, India, Finland Economic SWOT
Russia, Spain, United Kingdom, India, Finland Business Environment SWOT
Pharmaceutical Risk/Reward Ratings
Table: CEE Pharmaceutical Risk/Reward Ratings, Q213
Competitive Landscape
Manufacturing Sector
Company Activity
Wholesale Sector
Retail Sector
Company Profiles
Berlin-Chemie/Menarini Pharma GmbH

About Us

Market Research Reports.biz is the most comprehensive collection of market research reports. Market Research Reports.biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.


M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: +1-866-997-4948

Browse Market Research Blog:

Blog: Markets News